Review of the disease course among adult ulcerative colitis population-based longitudinal cohorts

Inflammatory Bowel Diseases

Volumn 18, Issue 3, 2012, Pages 573-583

  Magro, Fernando ^a,b   Rodrigues, Andreia ^c   Vieira, Ana Isabel ^d   Portela, Francisco ^e   Cremers, Isabelle ^f   Cotter, José ^g   Correia, Luis ^h   Duarte, Maria Antõnia ⁱ   Tavares, Maria Lourdes ^h   Lago, Paula ^j   Ministro, Paula ^k   Peixe, Paula ^l   Lopes, Susana ^b   Garcia, Elizabeth Benito ^c  

^a University of Porto   (Portugal)

^b HOSPITAL DE SÃO JOÃO   (Portugal)

^c BioEPI Clinical and Translational Research Center   (Portugal)

^d HOSPITAL GARCIA DE ORTA   (Portugal)

^e CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^f HOSPITAL DE SÃO BERNARDO   (Portugal)

^g Gastroenterology Department   (Portugal)

^h HOSPITAL DE SANTA MARIA   (Portugal)

ⁱ HOSPITAL DO DIVINO ESPÍRITO SANTO   (Portugal)

^j HOSPITAL DE SANTO ANTÓNIO   (Portugal)

^k Hospital S Teotonio   (Portugal)

^l HOSPITAL EGAS MONIZ   (Portugal)

more..

Author keywords

clinical course; clinical course and ulcerative colitis; cohort

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METHOTREXATE; SALAZOSULFAPYRIDINE; SALICYLIC ACID DERIVATIVE; STEROID; TUMOR NECROSIS FACTOR INHIBITOR;

ABSCESS; BILE DUCT CARCINOMA; BLEEDING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; COHORT ANALYSIS; COLON CANCER; COLON RESECTION; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE PERFORATION; LONG TERM CARE; LONGITUDINAL STUDY; MEDICAL HISTORY; MEDLINE; MORTALITY; POSTOPERATIVE COMPLICATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RELAPSE; REVIEW; SEPSIS; SMOKING; STEROID THERAPY; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; HUMANS; LONGITUDINAL STUDIES; RECURRENCE;

EID: 84857356639     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21815     Document Type: Review

References (47)

1. Feagan BG, Reinisch W, Rutgeerts P, et al. The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients. Am J Gastroenterol. 2007; 102: 794-802. (Pubitemid 46496629)
2. Committee for Medicinal Products for Human Use. Guideline on the development of new medicinal products for the treatment of ulcerative colitis. European Medicines Agency 2008.
3. Allison J, Herrinton LJ, Liu L, et al. Natural history of severe ulcerative colitis in a community-based health plan. Clin Gastroenterol Hepatol. 2008; 6: 999-1003.
4. Cabrera K, Schwartz RW,. Ulcerative colitis: natural history and medical management. Curr Surg. 2001; 58: 195-197. (Pubitemid 33666941)
5. Cullinan ER, Macdougall IP,. The natural history of ulcerative colitis. Lancet. 1957; 272: 487-489.
6. Cullinan ER, Macdougall IP,. The natural history of ulcerative colitis. Gastroenterologia. 1956; 86: 582-590.
7. Edwards FC, Truelove SC,. The course and prognosis of ulcerative colitis. Gut. 1963; 4: 299-315.
8. Filik L, Dagli U,. A retrospective evaluation of the history of treated ulcerative colitis. Bratisl Lek Listy. 2009; 110: 253-257.
9. Hodgson HJ,. The natural history of treated ulcerative colitis. Gastroenterology. 1994; 107: 300-302. (Pubitemid 24195373)
10. Matsumoto T,. [Natural history and long-term outcome of ulcerative colitis.] Nippon Shokakibyo Gakkai Zasshi. 2009; 106: 969-977.
11. Meyers S, Janowitz HD,. The "natural history" of ulcerative colitis: an analysis of the placebo response. J Clin Gastroenterol. 1989; 11: 33-37. (Pubitemid 19060140)
12. Selby W,. The natural history of ulcerative colitis. Baillieres Clin Gastroenterol. 1997; 11: 53-64. (Pubitemid 27237041)
13. Texter EC Jr,. The natural history of ulcerative colitis. J Chronic Dis. 1957; 5: 347-369.
14. Ebers GC,. Prognostic factors for multiple sclerosis: the importance of natural history studies. J Neurol. 2005; 252 (suppl 3): iii15-iii20. (Pubitemid 41355780)
15. Blettner M, Sauerbrei W, Schlehofer B, et al. Traditional reviews, meta-analyses and pooled analyses in epidemiology. Int J Epidemiol. 1999; 28: 1-9. (Pubitemid 29086203)
16. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000; 283: 2008-2012. (Pubitemid 30214957)
17. Pedersen N, Duricova D, Elkjaer M, et al. Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol. 2010; 105: 1480-1487.
18. Jess T, Gamborg M, Munkholm P, et al. Overall and cause-specific mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007; 102: 609-617. (Pubitemid 46328133)
19. Geboes K, Colombel JF, Greenstein A, et al. Indeterminate colitis: a review of the concept-what's in a name? Inflamm Bowel Dis. 2008; 14: 850-857. (Pubitemid 351898070)
20. Yang CH, Chen X, Dai J, et al. [The application of Montreal classification in inflammatory bowel disease.] Zhonghua Nei Ke Za Zhi. 2008; 47: 7-10.
21. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55: 749-753. (Pubitemid 43764536)
22. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (suppl A): 5-36.
23. Moum B, Ekbom A, Vatn MH, et al. Clinical course during the 1st year after diagnosis in ulcerative colitis and Crohn's disease. Results of a large, prospective population-based study in southeastern Norway, 1990-93. Scand J Gastroenterol. 1997; 32: 1005-1012. (Pubitemid 27433664)
24. Henriksen M, Jahnsen J, Lygren I, et al. Ulcerative colitis and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis. 2006; 12: 543-550. (Pubitemid 43977734)
25. Froslie KF, Jahnsen J, Moum BA, et al. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology. 2007; 133: 412-422. (Pubitemid 47187355)
26. Solberg IC, Lygren I, Jahnsen J, et al. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol. 2009; 44: 431-440.
27. Langholz E, Munkholm P, Davidsen M, et al. Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology. 1992; 103: 1444-1451.
28. Langholz E, Munkholm P, Davidsen M, et al. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology. 1994; 107: 3-11. (Pubitemid 24195339)
29. Langholz E, Munkholm P, Davidsen M, et al. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol. 1996; 31: 260-266.
30. Winther KV, Jess T, Langholz E, et al. Survival and cause-specific mortality in ulcerative colitis: follow-up of a population-based cohort in Copenhagen County. Gastroenterology. 2003; 125: 1576-1582. (Pubitemid 37500420)
31. Winther KV, Jess T, Langholz E, et al. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen County. Clin Gastroenterol Hepatol. 2004; 2: 1088-1095. (Pubitemid 40037640)
32. Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007; 13: 481-489. (Pubitemid 46668255)
33. Witte J, Shivananda S, Lennard-Jones JE, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol. 2000; 35: 1272-1277. (Pubitemid 32051641)
34. Hoie O, Wolters F, Riis L, et al. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol. 2007; 102: 1692-1701. (Pubitemid 47206689)
35. Hoie O, Wolters FL, Riis L, et al. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology. 2007; 132: 507-515.
36. Loftus EV Jr, Silverstein MD, Sandborn WJ, et al. Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut. 2000; 46: 336-343. (Pubitemid 30313384)
37. Jess T, Loftus EV Jr, Velayos FS, et al. Incidence and prognosis of colorectal dysplasia in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Inflamm Bowel Dis. 2006; 12: 669-676. (Pubitemid 44253749)
38. Jess T, Loftus EV Jr, Velayos FS, et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted County, Minnesota. Gastroenterology. 2006; 130: 1039-1046.
39. Jess T, Loftus EV Jr, Harmsen WS, et al. Survival and cause specific mortality in patients with inflammatory bowel disease: a long term outcome study in Olmsted County, Minnesota, 1940-2004. Gut. 2006; 55: 1248-1254. (Pubitemid 44277354)
40. Loftus CG, Loftus EV Jr, Harmsen WS, et al. Update on the incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota, 1940-2000. Inflamm Bowel Dis. 2007; 13: 254-261. (Pubitemid 46465905)
41. Bernstein CN, Blanchard JF, Rawsthorne P, et al. Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999; 149: 916-924. (Pubitemid 29230706)
42. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001; 96: 1116-1122. (Pubitemid 32319146)
43. Vind I, Riis L, Jess T, et al. Increasing incidences of inflammatory bowel disease and decreasing surgery rates in Copenhagen City and County, 2003-2005: a population-based study from the Danish Crohn colitis database. Am J Gastroenterol. 2006; 101: 1274-1282. (Pubitemid 43833122)
44. Rioux K,. What is the prognosis of ulcerative colitis? Inflamm Bowel Dis. 2008; 14 (suppl 2): S52-53.
45. Morrison G, Headon B, Gibson P,. Update in inflammatory bowel disease. Aust Fam Physician. 2009; 38: 956-961.
46. Faubion WA Jr, Loftus EV Jr, Harmsen WS, et al. The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study. Gastroenterology. 2001; 121: 255-260. (Pubitemid 32729372)
47. Louis E, Belaiche J, Reenaers C,. Do clinical factors help to predict disease course in inflammatory bowel disease? World J Gastroenterol. 2010; 16: 2600-2603.